Fingolimod Capsule
Product Images NDC 43547-003

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Fingolimod (NDC 43547-003). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Solco Healthcare Us, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemically Structure (Image 01)

Chemical structure of fingolimod, showing its molecular formula with distinct functional groups including hydroxyl and amine groups.*

FDA Label Image

Figure 1 (Image 02)

A line graph comparing the percentage of patients with three-month confirmed progression over time (days) between Fingolimod Capsules 0.5 mg and Placebo treatment groups. The graph shows progression percentages increasing over 720 days, with the Placebo group reaching 24% and the Fingolimod group 18%, illustrating differences in patient outcomes between the two groups.*

FDA Label Image

0.5mg (Image 03)

Label for Fingolimod Capsules 0.5 mg oral capsules by Solco Healthcare US, LLC. The label details 30 capsules per container and includes storage instructions, manufacturer and distributor information, and a reminder for pharmacists to dispense the Medication Guide.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.